Jump to content

apfelblosm

Members
  • Posts

    22
  • Joined

  • Last visited

  • Country

    United States

Reputation Activity

  1. Like
    apfelblosm reacted to marvy1 in Echo Users- seeing huge tube vs Echo discrepencies?   
    We get a lot of patients reacting like this. Attribute reactivity on the Echo to an autoantibody. Do need notice cold autos coming up that much, so assume it is a warm (Echo supposedly on reacts with IgG). I'm guessing if you do tube DAT it might be microscopically positive for IgG? If saline IAT  tube reactivity is negative we issue blood that is compatible by that method, especially if the patient was not recently transfused. I find autoantibodies love solid phase method.
  2. Like
    apfelblosm reacted to tbostock in Antisera   
    Yes I would cease and desist, for all the reasons above. 
     
    100% in agreement with Scott's comment: your new job is to look at everything and evaluate all old practices and determine:
    Are they in line with the regs and package inserts?
    Are they now considered best practice, or is this just an old thing that we keep doing?
    Does it add value?
    Does it add unnecessary cost to the organization?
    Is it delaying care by doing unnecessary procedures?
     
    It's very uncomfortable to get people out of their comfort zones, but it's very important to do it when needed.
  3. Like
    apfelblosm got a reaction from tupton in Need opinions...Giving Ag neg units vs. antibody "rule-out"   
    FYI- we recently had an anti-K that did show dosage and did only react with the homozygous cells.  We have a reference laboratory here.  We recently just changed our procedures to include ruling out on two heterozygous or one homozygous cell. 
     
    We are a 1250 bed, tertiary level 1 trauma center.
     
    Thanks!
    Jen, MT(ASCP)SBB
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.